Studies on GBM cells show eIF5B depletion leads to reduced cell growth due to inhibition of the NF-κB pathway and sensitization to temozolomide (TMZ)-mediated apoptosis (Ross et al., 2019, 2020). This evidence concerns the gene EIF5B and glioblastoma.